DermatologyNews.net

Dermatology Xagena

XagenaNewsletter
Xagena Mappa
Medical Meeting
Mediexplorer.it

Search results for "Psoriasis"

A Phase III study designed to evaluate the efficacy and safety of BG-12, an oral fumarate, in the treatment of moderate to severe psoriasis, met the primary endpoint. The patients receiving BG-12 de ...


In the IMPACT ( Infliximab Multinational Psoriatic Arthritis Controlled Trial ) study, 104 patients with active psoriatic arthritis who had failed at least one DMARD ( disease-modifying antirheumatic ...


High levels of estrogen correlated with improvement in psoriasis, whereas progesterone levels did not correlate with psoriatic change. The study investigated prospectively how psoriasis fluctuates ...


FDA ( Food and Drug Administration ) approved an expanded indication for Enbrel ( Etanercept ) to improve physical function in patients with psoriatic arthritis. In addition, the FDA approved an up ...


Bacterial resistance to conventional antibiotics has become increasingly common, resulting in escalating life-threatening infections. In an effort to find an alternative treatment for antibiotic-re ...


CHMP, the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency ( EMEA ), has issued a positive opinion recommending approval of Adalimumab ( Humi ...


Raptiva ( Efalizumab) is indicated for the treatment of adult patients ( 18 years or older ) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ...


The European Commission has granted approval of Remicade ( Infliximab ), an anti-tumor necrosis factor alpha ( TNF-alpha ) blocker, for the treatment of moderate to severe plaque psoriasis. The new ...


Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to ...


Cigarette smoking is associated with the clinical severity of the skin disease psoriasis, and both smoking and obesity are more prevalent among psoriasis patients. Psoriasis is a chronic, persisten ...


Researchers at Yale School of Medicine have demonstrated that Langerhans cells in the skin, which had been thought to alert the immune system to pathogens, instead dampen the skin's reaction to infect ...


Two clinical trials of Humira ( Adalimumab ), REVEAL and CHAMPION, have demonstrated promising results in psoriasis. Psoriasis is a chronic autoimmune disease that speeds the growth cycle of skin ...


A study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of Ustekinumab ( Stelara ) achieved at least a 75 percent reduction in psoriasis at we ...


Researchers at Washington University School of Medicine in St. Louis have discovered seven new sites of common DNA variation that increase the risk of this skin condition. They also found that variati ...


Raptiva ( Efalizumab ) is an immunosuppressive, humanized monoclonal antibody indicated for treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to ...